Understanding the FOLFOXIRI-regimen to optimize treatment for metastatic colorectal cancer

Por Sunakawa, Yu, Schirripa, Marta, Lenz, Heinz-Josef
Publicado no Crit Rev Oncol Hematol (2016)

Regorafenib in Japanese patients with solid tumors: phase I study of safety, efficacy, and pharmacokinetics

Por Sunakawa, Yu, Furuse, Junji, Okusaka, Takuji, Ikeda, Masafumi, Nagashima, Fumio, Ueno, Hideki, Mitsunaga, Shuichi, Hashizume, Kensei, Ito, Yuichiro, Sasaki, Yasutsuna
Publicado em 2013

Erratum to: Regorafenib in Japanese patients with solid tumors: phase I study of safety, efficacy, and pharmacokinetics

Por Sunakawa, Yu, Furuse, Junji, Okusaka, Takuji, Ikeda, Masafumi, Nagashima, Fumio, Ueno, Hideki, Mitsunaga, Shuichi, Hashizume, Kensei, Ito, Yuichiro, Sasaki, Yasutsuna
Publicado em 2013

Germline polymorphisms in genes involved in the Hippo pathway as recurrence biomarkers in stage II/III colon cancer

Por Sebio, Ana, Matsusaka, Satoshi, Zhang, Wu, Yang, Dongyun, Ning, Yan, Stremitzer, Stefan, Stintzing, Sebastian, Sunakawa, Yu, Yamauchi, Shinichi, Fujimoto, Yoshiya, Ueno, Masashi, Lenz, Heinz-Josef
Publicado no Pharmacogenomics J (2015)

Genetic variants within obesity-related genes are associated with tumor recurrence in patients with stages II/III colon cancer

Por Sebio, Ana, Gerger, Armin, Matsusaka, Satoshi, Yang, Dongyun, Zhang, Wu, Stremitzer, Stefan, Stintizing, Sebastian, Sunakawa, Yu, Yamauchi, Shinichi, Ning, Yan, Fujimoto, Yoshiya, Ueno, Masashi, Lenz, Heinz-Josef
Publicado no Pharmacogenet Genomics (2015)

A phase I study of farletuzumab, a humanized anti-folate receptor α monoclonal antibody, in patients with solid tumors

Por Sasaki, Yasutsuna, Miwa, Keisuke, Yamashita, Keishi, Sunakawa, Yu, Shimada, Ken, Ishida, Hiroo, Hasegawa, Kosei, Fujiwara, Keiichi, Kodaira, Makoto, Fujiwara, Yasuhiro, Namiki, Masayuki, Matsuda, Minami, Takeuchi, Yutaka, Katsumata, Noriyuki
Publicado no Invest New Drugs (2014)

Genetic variations in angiopoietin and pericyte pathways and clinical outcome in patients with resected colorectal liver metastases

Por Stremitzer, Stefan, Zhang, Wu, Yang, Dongyun, Ning, Yan, Stintzing, Sebastian, Sebio, Ana, Sunakawa, Yu, Yamauchi, Shinichi, Matsusaka, Satoshi, El-Khoueiry, Rita, Stift, Judith, Wrba, Friedrich, Gruenberger, Thomas, Lenz, Heinz-Josef
Publicado no Cancer (2015)

Early tumor shrinkage as a predictor of favorable outcomes in patients with advanced pancreatic cancer treated with FOLFIRINOX

Por Kaga, Yasuhiro, Sunakawa, Yu, Kubota, Yutaro, Tagawa, Teppei, Yamamoto, Taikan, Ikusue, Toshikazu, Uto, Yu, Miyashita, Kouichirou, Toshima, Hirokazu, Kobayashi, Kouji, Hisamatsu, Atsushi, Ichikawa, Wataru, Sekikawa, Takashi, Shimada, Ken, Sasaki, Yasutsuna
Publicado no Oncotarget (2016)

Prognostic Impact of IL-6 Genetic Variants in Patients with Metastatic Colorectal Cancer Treated with Bevacizumab-Based Chemotherapy

Por Matsusaka, Satoshi, Hanna, Diana L., Cao, Shu, Zhang, Wu, Yang, Dongyun, Ning, Yan, Sunakawa, Yu, Okazaki, Satoshi, Berger, Martin D., Miyamato, Yuji, Parekh, Anish, Stintzing, Sebastian, Loupakis, Fotios, Lenz, Heinz-Josef
Publicado no Clin Cancer Res (2016)

Plastin polymorphisms predict genderand stage-specific colon cancer recurrence after adjuvant chemotherapy

Por Ning, Yan, Gerger, Armin, Zhang, Wu, Hanna, Diana L, Yang, Dongyun, Winder, Thomas, Wakatsuki, Takeru, Labonte, Melissa J, Stintzing, Sebastian, Volz, Nico, Sunakawa, Yu, Stremitzer, Stefan, El-Khoueiry, Rita, Lenz, Heinz-Josef
Publicado em 2013

Cytokeratin-20 and Survivin Expressing Circulating Tumor Cells Predict Survival in Metastatic Colorectal Cancer Patients by a Combined Immunomagnetic qRT-PCR Approach

Por Ning, Yan, Hanna, Diana L, Zhang, Wu, Mendez, Angela, Yang, Dongyun, El-Khoueiry, Rita, Matsusaka, Satoshi, Sunakawa, Yu, Stremitzer, Stefan, Parekh, Anish, Okazaki, Satoshi, Berger, Martin D., Barzi, Afsaneh, Lenz, Heinz-Josef
Publicado no Mol Cancer Ther (2015)

TWIST1 polymorphisms predict survival in patients with metastatic colorectal cancer receiving first-line bevacizumab plus oxaliplatin-based chemotherapy

Por Matsusaka, Satoshi, Zhang, Wu, Cao, Shu, Hanna, Diana L., Sunakawa, Yu, Sebio, Ana, Ueno, Masashi, Yang, Dongyun, Ning, Yan, Parekh, Anish, Okazaki, Satoshi, Berger, Martin D., Ichikawa, Wataru, Mizunuma, Nobuyuki, Lenz, Heinz-Josef.
Publicado no Mol Cancer Ther (2016)

Single nucleotide polymorphisms in AREG and EREG are prognostic biomarkers in locally advanced gastric cancer (GC) patients after surgery with curative intent

Por Wakatsuki, Takeru, Stintzing, Sebastian, Zhang, Wu, Yang, Dongyun, Azuma, Mizutomo, Ning, Yan, Yamauchi, Shinichi, Matsusaka, Satoshi, Volz, Nico B., Sunakawa, Yu, Koizumi, Wasaburo, Watanabe, Masahiko, Barzi, Afsaneh, El Khoueiry, Anthony B, Shah, Manish A, Lenz, Heinz-Josef
Publicado em 2014

Impact of sex, age, and ethnicity/race on the survival of patients with rectal cancer in the United States from 1988 to 2012

Por Berger, Martin D., Yang, Dongyun, Sunakawa, Yu, Zhang, Wu, Ning, Yan, Matsusaka, Satoshi, Okazaki, Satoshi, Miyamoto, Yuji, Suenaga, Mitsukuni, Schirripa, Marta, Lenz, Annika Medea, Bohanes, Pierre, Barzi, Afsaneh, Figueiredo, Jane C., Hanna, Diana L., Lenz, Heinz-Josef
Publicado no Oncotarget (2016)

Prognostic impact of c-MET polymorphism on clinical outcome in loco-regional gastric cancer patients

Por Sunakawa, Yu, Wakatsuki, Takeru, Yang, Dongyun, Zhang, Wu, Ning, Yan, Stintzing, Sebastian, Stremitzer, Stefan, Yamauchi, Shinichi, Sebio, Ana, El-khoueiry, Rita, Iqbal, Syma, Afsaneh, Barzi, Gerger, Armin, Stotz, Michael, Azuma, Mizutomo, Watanabe, Masahiko, Koizumi, Wasaburo, Lenz, Heinz-Josef
Publicado no Pharmacogenet Genomics (2014)

Polymorphisms in genes involved in EGFR-turnover are predictive for cetuximab efficacy in colorectal cancer

Por Stintzing, Sebastian, Zhang, Wu, Heinemann, Volker, Neureiter, Daniel, Kemmerling, Ralf, Kirchner, Thomas, Jung, Andreas, Folwaczny, Matthias, Yang, Dongyun, Ning, Yan, Sebio, Ana, Stremitzer, Stefan, Sunakawa, Yu, Matsusaka, Satoshi, Yamauchi, Shinichi, Loupakis, Fotios, Cremolini, Chiara, Falcone, Alfredo, Lenz, Heinz-Josef
Publicado no Mol Cancer Ther (2015)

Combined assessment of EGFR-related molecules to predict outcome of 1st-line cetuximab-containing chemotherapy for metastatic colorectal cancer

Por Sunakawa, Yu, Yang, Dongyun, Moran, Miriana, Astrow, Stephanie H., Tsuji, Akihito, Stephens, Craig, Zhang, Wu, Cao, Shu, Takahashi, Takehiro, Denda, Tadamichi, Shimada, Ken, Kochi, Mitsugu, Nakamura, Masato, Kotaka, Masahito, Segawa, Yoshihiko, Masuishi, Toshiki, Takeuchi, Masahiro, Fujii, Masashi, Nakajima, Toshifusa, Ichikawa, Wataru, Lenz, Heinz-Josef
Publicado no Cancer Biol Ther (2016)

Clinical significance of TLR1 I602S polymorphism for patients with metastatic colorectal cancer treated with FOLFIRI plus bevacizumab

Por Okazaki, Satoshi, Loupakis, Fotios, Stintzing, Sebastian, Cao, Shu, Zhang, Wu, Yang, Dongyun, Ning, Yan, Sunakawa, Yu, Stremitzer, Stefan, Matsusaka, Satoshi, Berger, Martin D., Parekh, Anish, West, Jordan D., Miyamoto, Yuji, Suenaga, Mitsukuni, Schirripa, Marta, Cremolini, Chiara, Falcone, Alfredo, Heinemann, Volker, DePaolo, R. William, Lenz, Heinz-Josef
Publicado no Mol Cancer Ther (2016)